Literature DB >> 11108865

Ovarian steroids in endometrial angiogenesis.

M Perrot-Applanat1, M Ancelin, H Buteau-Lozano, G Meduri, P Bausero.   

Abstract

Angiogenesis, the sprouting of new blood vessels from pre-existing ones, is fundamental for human endometrial development and differentiation, which are necessary for implantation. This vascular process is supposed to be mainly mediated by the vascular endothelial growth factor (VEGF), also named vascular permeability factor (VPF). We report here the expression and modulation of VEGF and its receptors, Flk-1/KDR and Flt-1, in the functionalis throughout the menstrual cycle. Using immunocytochemistry, VEGF is localized in glandular epithelial cells and in the surrounding stroma, as well as in capillaries and spiral arterioles. The localization of VEGF on the endothelium correlates with the presence of Flt-1 and Flk-1/KDR receptors on vascular structures, including capillary strands that have not yet formed a lumen and that have been previously described in tumors as angiogenic capillaries. The strongest immunoreactivity for both VEGF and Flk-1/KDR receptor on endothelial cells is detected in the proliferative and midsecretory phases. Enhanced expression of VEGF and its Flk-1 receptors on narrow capillary strands during the proliferative phase may account for the rapid capillary growth associated with endometrial regeneration from the residual basal layer following menstrual shedding of the functionalis. The vascular expression of Flt-1 is more important in the secretory than in the proliferative phase, associated with a high microvascular density and an increase in vascular permeability in the implantation period. Consistently with these in vivo observations, the treatment of isolated endometrial stromal cells with estradiol (E(2)), or E(2) + progesterone, significantly increased VEGF mRNA over the control value in a dose-dependent manner. These results demonstrate that the expression of VEGF and its receptors is cyclically modulated by ovarian steroids, and that this endothelial growth factor acts on the endothelium in a paracrine fashion to control endometrial angiogenesis and permeability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108865     DOI: 10.1016/s0039-128x(00)00117-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  7 in total

1.  Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis.

Authors:  Michael J Jarzynka; Ping Guo; Ifat Bar-Joseph; Bo Hu; Shi-Yuan Cheng
Journal:  Int J Oncol       Date:  2006-02       Impact factor: 5.650

2.  Angiogenesis and capillary maturation phenotypes associated with the Edpm3 locus on rat chromosome 3.

Authors:  Jyotsna Pandey; Douglas L Wendell
Journal:  Mamm Genome       Date:  2006-01-13       Impact factor: 3.224

3.  Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation.

Authors:  Yuko Matsubara; Keiichi Matsubara
Journal:  Reprod Biol Endocrinol       Date:  2012-01-17       Impact factor: 5.211

Review 4.  Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal Immunity.

Authors:  Kameliya Vinketova; Milena Mourdjeva; Tsvetelina Oreshkova
Journal:  J Pregnancy       Date:  2016-04-28

Review 5.  Solving the Puzzle: What Is the Role of Progestogens in Neovascularization?

Authors:  Zhi Xia; Jian Xiao; Qiong Chen
Journal:  Biomolecules       Date:  2021-11-12

Review 6.  Involvement of androgens in ovarian health and disease.

Authors:  M Lebbe; T K Woodruff
Journal:  Mol Hum Reprod       Date:  2013-09-10       Impact factor: 4.025

7.  Enhanced Stromal Cell CBS-H2S Production Promotes Estrogen-Stimulated Human Endometrial Angiogenesis.

Authors:  Qian-Rong Qi; Thomas J Lechuga; Basari Patel; Nicole A Nguyen; Yi-Hua Yang; Yan Li; Sassi Sarnthiyakul; Quan-Wei Zhang; Jin Bai; Josh Makhoul; Dong-Bao Chen
Journal:  Endocrinology       Date:  2020-11-01       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.